Recruiting

RayStation & RayCare

Sponsor:

University of Wisconsin, Madison

Code:

NCT07949773

Conditions

Radiation

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Interventions

RayTracker and RayAdaptive Software Analysis

Study Details

Brief summary:

This study is being done to evaluate the clinical utilization and safety of RayStation 2025 and RayCare 2025 treatment planning software upgrades when used to support standard-of-care proton therapy delivery in patients deemed clinically appropriate for such therapy by their treating radiation oncologist.

Conditions

Radiation

Study ID

NCT07949773

Start date

Oct 13, 2026

Status verified date

Nov, 2026

Completion date

Jan, 2029

Anticipated

Primary completion date

Jan, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age less than or equal to 17 years at the time of consent/assent.
  • Patient has a clinical indication for radiation therapy, and the treating radiation oncologist has independently determined that proton therapy is clinically appropriate and has recommended proton therapy as part of the patient's routine clinical care, independent of participation in this research study. Proton therapy may be delivered with or without anesthesia when clinically indicated.
  • Written informed consent will be obtained from adult subjects or the parent/legal guardian of pediatric subjects. Assent will be obtained from pediatric participants when appropriate according to institutional policy.

Exclusion Criteria:

  • Patient has contraindications to proton therapy (per standard clinical guidelines).
  • Patient is unable to comply with routine treatment workflow or follow-up.
  • Patients who will be treated with a radiation plan of 5 fractions or fewer.

Study Design

Enrollment

80 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Standard of Care Proton Therapy

Interventions

RayTracker and RayAdaptive Software Analysis

Part of a not yet FDA-cleared software, the RaySearch treatment planning system and RayCare oncology information system. RayTracker enables longitudinal evaluation of treatment by recalculating dose on daily images and accumulating dose across fractions using deformable image registration, thereby providing an estimate of the cumulative delivered dose to targets and organs at risk. RayAdaptive uses daily treatment imaging (such as cone-beam CT (CBCT)) together with the planning CT to generate an updated representation of patient anatomy and recalculation of dose on the current patient anatomy, allowing clinicians to evaluate whether anatomical changes could meaningfully alter the planned dose distribution. These features are designed to be used in tandem. Their combined capabilities are intended to support clinical decision-making related to treatment monitoring and potential adaptation.

Primary outcome measure

  • Proportion of verification image assessments for each subject resulting in a clinical adaptive replanning decision [ Time Frame: up to 6 months ]

Central Contacts and Locations

Central contacts

Locations

University of Wisconsin

Recruiting

Madison, Wisconsin, United States, 53792

More Information

Sponsor

University of Wisconsin, Madison

Last update posted

Nov 19, 2026

Last verified

Nov, 2026

Keywords

  • Proton Therapy
  • Treatment Planning Software
  • clinical decision support tool
  • image analysis

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by University of Wisconsin, Madison on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.